Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJosé Baselga, John Mendelsohn, Andrew D. Seidman et al.|Journal of Clinical Oncology|2000Cited by 746
The epidermal growth factor receptor as a target for cancer therapy.John Mendelsohn|Endocrine Related Cancer|2001Cited by 331
Understanding continent-wide variation in vulture ranging behavior to assess feasibility of Vulture Safe Zones in Africa: Challenges and possibilitiesAdam Kane, Corinne J. Kendall, Ara Monadjem et al.|Biological Conservation|2022Cited by 23